MIT’s Hadley Sikes has developed a sensor that determines whether cancer cells respond to a particular type of chemotherapy by detecting hydrogen peroxide inside human cells.
The technology could help identify new cancer drugs that boost levels of hydrogen peroxide, which induces programmed cell death. The sensors could also be adapted to screen individual patients’ tumors to predict whether such drugs would be effective against them.
Join ApplySci at the 9th Wearable Tech + Digital Health + Neurotech Boston conference on September 24, 2018 at the MIT Media Lab. Speakers include: Rudy Tanzi – Mary Lou Jepsen – George Church – Roz Picard – Nathan Intrator – Keith Johnson – Juan Enriquez – John Mattison – Roozbeh Ghaffari – Poppy Crum – Phillip Alvelda –Marom Bikson – Ed Simcox – Sean Lane